💡 ¿Quimio o inmunoterapia?
Para pacientes #MSI-H / #dMMR, hay nuevas opciones👇
✔ Más eficacia
✔ Menos toxicidad
✔ Mejores resultados
#CáncerColorrectal #Oncología #Inmunoterapia #TerapiasDirigidas #TratamientoDelCancer #InmunoOncologia #InnovacionMedica #DengYueMedicinasEnHongKong

@weoncologists.bsky.social summarizes the @oncoalert.bsky.social round-up 🤠

#SuppOnc dataon #GA the pillar assessment for #olderadults

#GIonc includes #agnostic treatments in #dMMR cancer 🧬

Be sure to not miss an update by signing up 🔗: oncoalert360.com OR oncoalert.m-pages.com/nhMpwe/oncoa...

Nonoperative Management of #dMMR #Tumors - A Patient-Centered Approach www.nejm.org/doi/10.1056/... #hvhebron #onco

Further analysis of the RUBY trial (Part 1) focuses on patients with dMMR/MSI-H primary advanced or recurrent EC, highlighting the consistent benefits of adding dostarlimab to CT.

@GynecologicOncology

#Onco404 #Cancer #Kanser #Immunotherapy #EndometrialCancer #dMMR #MSI #Dostarlimab

Oncology's Green Light Podcast · OncologyResearch · FDA Approvals: AI-Powered Insights for everyday oncology clinicians

🎧 Stay informed and join the conversation! #ColorectalCancer #Immunotherapy #MSIH #dMMR #FDAapproval #Oncology #CheckMate8HW #MedicalInnovation #FDA #Nivolumab #Ipilimumab
open.spotify.com/show/6yKyfXw...

Cancer Breakthrough? Jemperli vs. Surgery for Some Patients A new study announces exciting results for certain solid tumors. Is Jemperli a cancer breakthrough? If the cancers are "dMMR," quite possibly!

Cancer Breakthrough? Jemperli vs. Surgery for Some Patients www.peoplespharmacy.com/articles/can... via @peoplespharmacy

#cancer #dMMR #Jemperli #surgery #cancerbreakthrough #health

Organ Preservation in dMMR Tumors: Results from Neoadjuvant Phase II Study with Dostarlimab - OncoDaily Neoadjuvant dostarlimab enables nonoperative management of dMMR tumors, achieving 100% CR in rectal c-r and high organ preservation rates.

Organ Preservation in dMMR Tumors: Results from Neoadjuvant Phase II Study with Dostarlimab

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #dMMR #Dostarlimab #ColonCancer

Paradigm Shift? Neoadjuvant Immunotherapy Enables Organ Preservation in Early-Stage dMMR Solid Tumors!🧬

@nejm.org #NEJM

#Onco404 #Cancer #Kanser #Oncology #Immunotherapy #İmmünoterapi #PrecisionMedicine #dMMR #Dostarlimab #OrganPreservation #ClinicalTrials #RectalCancer #MedTwitter

Happened this week: @FDA approves Nivo/Ipi vs. Nivo alone for #MSIhigh or #dMMR met #colorectal #cancer #Checkmate8HW
☑️Median PFS was NR in the combo arm vs. 39.3M (HR = 0.62 [95% CI: 0.48, 0.81]
☑️ORR = 71% vs. 58% (p-value 0.0011)
#CancerResearch #immunotherapy @bristolmyerssquibb.bsky.social

Ipilimumab and Nivolumab for dMMR/MSI-H Colorectal Cancer Ipilimumab and Nivolumab approved for MSI-H/dMMR metastatic colorectal cancer. Learn about the CheckMate 8HW trial results.

FDA Approves Nivolumab and Ipilimumab for Unresectable or Metastatic MSI-H or dMMR Colorectal Cancer: CheckMate 8HW trial results
@fda.gov

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ColonCancer #ColorectalCancer #CRC #dMMR #FDAapproval

Interesting #GIonc read on #IO in #crcsm with #ctDNA 🩸🧬

#ctDNA helps detects #MRD for #dMMR stage III #crcsm it can guide treatment shifts:
ineffective chemo ➡️ #immunotherapy 🟰 ⬆️ outcomes

🔗: www.tandfonline.com/doi/full/10....